Vasanthavada Madhav 4

What Happened

• Vasanthavada Madhav, Chief Commercial Officer of Abeona Therapeutics, reported the sale of 5,548 shares on May 11, 2026. The shares were disposed in open-market/private sales with a weighted-average price of $5.96, for total proceeds of approximately $33,073. This sale was reported on Form 4.

Key Details

• Transaction date: 2026-05-11
• Trade type: Sale (S) — open market or private sale
• Shares sold: 5,548
• Price: weighted-average $5.96 per share; individual sale prices ranged from $5.90 to $6.00 (footnote F2)
• Proceeds: ~$33,073
• Footnote F1: The sale was executed to cover tax obligations tied to the vesting of restricted stock awards (i.e., tax withholding on vesting)
• Shares owned after the transaction: not specified in the provided filing
• Filing timeliness: Form filed with the same report date (no late filing indicated)

Context

• This transaction appears to be a tax-covering sell associated with vested restricted stock awards (common and generally considered routine). It does not necessarily signal a personal view on the company’s outlook. The weighted-average sale price and price range are disclosed; the filer offers to provide per-price breakdown upon request (F2).